SEATTLE, Jan. 29, 2018 -- According to Coherent Market Insights, the global coagulation analyzer market was valued at US$ 2,481.7 million in 2017 and is projected to exhibit a CAGR of 9.7% over the forecast period (2017–2025).
To know the latest trends and insights prevalent in this market, click the link below:
https://www.coherentmarketinsights.com/market-insight/coagulation-analyzers-market-1255
Key Trends and Analysis of the Coagulation Analyzer Market:
Introduction of new coagulation analyzers by manufacturers to perform various functions such as cap piercing, primary tube sampling, dilution, and automatic rerun is expected to boast growth of the market. For instance, in November 2015, Instrumentation Laboratory launched ACL TOP Family 50 series for mid- to high-volume clinical laboratories for routine to specialty assays, including clotting, chromogenic, and immunological assays. Moreover, in May 2016, Hoffmann-La Roche Ltd. launched CoaguChek INRange system — a Bluetooth enabled PT/INR home health device — in countries accepting the CE Mark that enable patients to check their coagulation status at home. Development of such devices contributes towards growth of coagulation analyzers market over the forecast period.
Anticoagulation Self-Monitoring Alliance and Anticoagulation Europe are taking initiatives to spread awareness of the ill-effects of anticoagulant therapy and have compelled lab technicians to monitor coagulant factors used during anticoagulant therapies. Furthermore, manufacturers are emphasizing on providing cost effective analyzers to small and medium-sized diagnostic laboratories. This is owing to these laboratories focusing on expanding in emerging economies such as India and China, which have less diagnostic centers, due to low disposable income and lack of infrastructure.
Request Sample Copy of this Report
Key Market Takeaways:
- A CAGR of 9.7% is expected during the forecast period (2017–2025), this is attributed to increasing adoption of handheld coagulation analyzers by clinical laboratories, which provides accurate results in low turnaround time.
- Increasing demand for testing reagents and kits by hospitals and other centers for diagnosis is expected to be factor for largest market share of these consumables in the coagulation analyzer market.
- Some of the major players in the global coagulation analyzer market include Siemens AG, Thermo Fisher Scientific Inc., Hoffmann-La Roche Ltd., Instrumentation Laboratory, Sysmex Corporation, Beckman Coulter, Inc. (Danaher), Diamond Diagnostics, International Technidyne Corporation, Nihon Kohden Corporation, and Alere Inc.
Contact Us:
Mr. Shah
Coherent Market Insights
1001 4th Ave.
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: [email protected]


OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
Ford and Geely Explore Strategic Manufacturing Partnership in Europe
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing 



